Despite these limitations, our study provides evidence suggesting that TERT genetic alterations may play a role in MBCs and that these are likely associated with specific subsets of the disease, emphasizing the diversity and molecular heterogeneity of MBCs. The gene discussed is TERT; the disease is maternal uniparental disomy of chromosome 20.